@article{MTMT:3215143,
 author = {Molnár, Tamás and Farkas, Klaudia and Rutka, Mariann and Ferenci, Tamás and Nagy, Ferenc and Bálint, Anita and Bor, Renáta and Milassin, Ágnes and Fábián, Anna and Végh, Z and Kürti, Zsuzsanna and Lakatos, Péter László and Szepes, Zoltán},
 doi = {10.1093/ecco-jcc/jjx002.799},
 eissn = {1876-4479},
 issn = {1873-9946},
 journal = {JOURNAL OF CROHNS & COLITIS},
 journal-iso = {J CROHNS COLITIS},
 orcid-numbers = {Molnár, Tamás/0000-0002-4913-7599; Farkas, Klaudia/0000-0003-0599-182X; Rutka, Mariann/0000-0003-2360-7836; Ferenci, Tamás/0000-0001-6791-3080; Bálint, Anita/0000-0002-3624-896X; Bor, Renáta/0000-0001-9393-5240; Milassin, Ágnes/0000-0001-6902-8915; Fábián, Anna/0000-0002-0824-7476; Kürti, Zsuzsanna/0000-0001-8671-6576; Lakatos, Péter László/0000-0002-3948-6488; Szepes, Zoltán/0000-0002-9466-8719},
 pages = {S425-S426},
 title = {Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission in Crohn's disease and ulcerative colitis - 54 week data.},
 unique-id = {3215143},
 url = {https://m2.mtmt.hu/api/publication/3215143},
 volume = {11},
 year = {2017}
}

